Literature DB >> 9792619

Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.

J D Jentsch1, C D Verrico, D Le, R H Roth.   

Abstract

Long-term abuse of marijuana by humans can induce profound behavioral deficits characterized by cognitive and memory impairments. In particular, deficits on tasks dependent on frontal lobe function have been reported in cannabis abusers. In the current study, we examined whether long-term exposure to delta9-tetrahydrocannabinol, the active ingredient in marijuana, altered the neurochemistry of the frontal cortex in rats. Two weeks administration of delta9-tetrahydrocannabinol reduced dopamine transmission in the medial prefrontal cortex, while dopamine metabolism in striatal regions was unaffected. These data are consistent with earlier findings of dopaminergic regulation of frontal cortical cognition. Thus, cognitive deficits in heavy abusers of cannabis may be subserved by drug-induced alterations in frontal cortical dopamine transmission.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792619     DOI: 10.1016/s0304-3940(98)00254-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Endocannabinoids and exercise.

Authors:  A Dietrich; W F McDaniel
Journal:  Br J Sports Med       Date:  2004-10       Impact factor: 13.800

Review 2.  The acute effects of cannabinoids on memory in humans: a review.

Authors:  Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2006-09-26       Impact factor: 4.530

3.  The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users.

Authors:  Alecia Dager Schweinsburg; Brian C Schweinsburg; Krista Lisdahl Medina; Tim McQueeny; Sandra A Brown; Susan F Tapert
Journal:  J Psychoactive Drugs       Date:  2010-09

Review 4.  The effects of Δ9-tetrahydrocannabinol on the dopamine system.

Authors:  Michael A P Bloomfield; Abhishekh H Ashok; Nora D Volkow; Oliver D Howes
Journal:  Nature       Date:  2016-11-17       Impact factor: 49.962

5.  Abnormal cerebellar morphometry in abstinent adolescent marijuana users.

Authors:  Krista Lisdahl Medina; Bonnie J Nagel; Susan F Tapert
Journal:  Psychiatry Res       Date:  2010-04-21       Impact factor: 3.222

Review 6.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

7.  Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison.

Authors:  Justine Renard; Marie-Odile Krebs; Thérèse M Jay; Gwenaëlle Le Pen
Journal:  Psychopharmacology (Berl)       Date:  2012-09-16       Impact factor: 4.530

8.  Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects.

Authors:  Krista Lisdahl Medina; Tim McQueeny; Bonnie J Nagel; Karen L Hanson; Tony T Yang; Susan F Tapert
Journal:  Addict Biol       Date:  2009-07-24       Impact factor: 4.280

9.  Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex.

Authors:  M Steffens; C Engler; J Zentner; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

10.  Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

Authors:  Deepak Cyril D'Souza; Gabriel Braley; Rebecca Blaise; Michael Vendetti; Stephen Oliver; Brian Pittman; Mohini Ranganathan; Savita Bhakta; Zoran Zimolo; Thomas Cooper; Edward Perry
Journal:  Psychopharmacology (Berl)       Date:  2008-01-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.